Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based on Imputed Placebo Effect

Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based... Cardiovasc Drugs Ther (2017) 31:295–301 DOI 10.1007/s10557-017-6728-z ORIGINAL ARTICLE Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based on Imputed Placebo Effect 1 1 1 Patrícia O. Guimarães & Renato D. Lopes & Daniel M. Wojdyla & 2 3 4 5 Azmil H. Abdul-Rahim & Stuart J. Connolly & Greg C. Flaker & Junyuan Wang & 6 1 7 2 Michael Hanna & Christopher B. Granger & Lars Wallentin & Kennedy R. Lees & 1 2 John H. Alexander & John J.V. McMurray Published online: 18 May 2017 Springer Science+Business Media New York 2017 Abstract patients with AF. We used results from meta-analyses of Purpose Vitamin K antagonists (VKAs) are the standard of randomized trials as our reference for the comparison between care for stroke prevention in patients with atrial fibrillation warfarin and placebo/no treatment, and aspirin and placebo/no (AF); therefore, there is not equipoise when comparing newer treatment. oral anticoagulants with placebo in this setting. Results In these meta-analyses, a lower rate of death was seen Methods To explore the effect of apixaban on mortality in both with warfarin (odds ratio [OR] 0.74, 95% confidence in- patients with AF, we performed a meta-analysis http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Cardiovascular Drugs and Therapy Springer Journals

Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based on Imputed Placebo Effect

Loading next page...
 
/lp/springer_journal/effect-of-apixaban-on-all-cause-death-in-patients-with-atrial-VG38OQpSrG
Publisher
Springer US
Copyright
Copyright © 2017 by Springer Science+Business Media New York
Subject
Medicine & Public Health; Cardiology
ISSN
0920-3206
eISSN
1573-7241
D.O.I.
10.1007/s10557-017-6728-z
Publisher site
See Article on Publisher Site

Abstract

Cardiovasc Drugs Ther (2017) 31:295–301 DOI 10.1007/s10557-017-6728-z ORIGINAL ARTICLE Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based on Imputed Placebo Effect 1 1 1 Patrícia O. Guimarães & Renato D. Lopes & Daniel M. Wojdyla & 2 3 4 5 Azmil H. Abdul-Rahim & Stuart J. Connolly & Greg C. Flaker & Junyuan Wang & 6 1 7 2 Michael Hanna & Christopher B. Granger & Lars Wallentin & Kennedy R. Lees & 1 2 John H. Alexander & John J.V. McMurray Published online: 18 May 2017 Springer Science+Business Media New York 2017 Abstract patients with AF. We used results from meta-analyses of Purpose Vitamin K antagonists (VKAs) are the standard of randomized trials as our reference for the comparison between care for stroke prevention in patients with atrial fibrillation warfarin and placebo/no treatment, and aspirin and placebo/no (AF); therefore, there is not equipoise when comparing newer treatment. oral anticoagulants with placebo in this setting. Results In these meta-analyses, a lower rate of death was seen Methods To explore the effect of apixaban on mortality in both with warfarin (odds ratio [OR] 0.74, 95% confidence in- patients with AF, we performed a meta-analysis

Journal

Cardiovascular Drugs and TherapySpringer Journals

Published: May 18, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off